Papers to watch

L.A. Banaszynski et al., "A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules," Cell, 126: 995-1004, Sept. 8, 2006. Destabilized mutants of the cytosolic protein FKBP12 are rapidly and constitutively degraded when expressed in mammalian cells but these unstable mutants can be rescued by addition of a synthetic FKBP12 ligand. When fused to other proteins, then ligand-induced rescue from degrad

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

L.A. Banaszynski et al., "A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules," Cell, 126: 995-1004, Sept. 8, 2006.

Destabilized mutants of the cytosolic protein FKBP12 are rapidly and constitutively degraded when expressed in mammalian cells but these unstable mutants can be rescued by addition of a synthetic FKBP12 ligand. When fused to other proteins, then ligand-induced rescue from degradation is also observed.

Sophie Jackson
University of Cambridge, United Kingdom

Extra: Stanford?s Tom Wandless is working to commercialize this technology. Click here to read more.

K.A. D'Amour et al., "Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells," Nat Biotechnol, 24:1392-401, Nov. 24, 2006.

This study uses a human embryonic stem cells and five-step protocol in vitro to recapitulate the normal embryonic developmental process that leads to the formation of insulin producing cells. The cells produced by using this protocol generate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies